Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
W.L. Gore & Associates said it launched a post-approval study of its Viabahn stent graft for treating peripheral artery disease.
The 108-patient Reline Max study will examine the treatment of in-stent restenosis in the superficial femoral artery using the Viabahn device, which is designed to inhibit blood clots with its heparin coating. Read more
Titan Medical said it licensed “know-how and certain technology” from Mayo Clinic for its Sport robot-assisted surgery platform.
The license covers intellectual property developed by Dr. David Larson, chairman of the colorectal surgery department at the Rochester, Minn.-based clinic, “including that developed through his participation in cadaver studies with Titan’s Sport surgical system,” Titan said. Read more
The U.S. House of Representatives today overwhelmingly passed a $1.15 trillion spending bill, which would avoid another federal shutdown and lift the 40-year-old ban on U.S. crude oil exports.
The bipartisan, 316-113 vote sends the bill to the Senate, where Republican and Democratic leaders have agreed to combine it with a tax package passed yesterday that included a 2-year moratorium on the medical device tax. Read more